Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience

BACKGROUND: Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that offer therapies with reduced side effects but reduced efficacy. We analysed the ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Straube, Christoph, Scherb, Hagen, Gempt, Jens, Bette, Stefanie, Zimmer, Claus, Schmidt-Graf, Friederike, Schlegel, Jürgen, Meyer, Bernhard, Combs, Stephanie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408447/
https://www.ncbi.nlm.nih.gov/pubmed/28454549
http://dx.doi.org/10.1186/s13014-017-0809-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408447/
https://www.ncbi.nlm.nih.gov/pubmed/28454549
http://dx.doi.org/10.1186/s13014-017-0809-9

Ejemplares similares